Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults
EJ Anderson, NG Rouphael, AT Widge… - … England Journal of …, 2020 - Mass Medical Soc
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
[HTML][HTML] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
EJ Anderson, NG Rouphael, AT Widge… - The New England … - ncbi.nlm.nih.gov
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
EJ Anderson, NG Rouphael, AT Widge… - The New England …, 2020 - europepmc.org
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults
EJ Anderson, NG Rouphael, AT Widge… - New England Journal …, 2020 - cdr.lib.unc.edu
BACKGROUND Testing of vaccine candidates to prevent infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
EJ Anderson, NG Rouphael… - The New England …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
EJ Anderson, NG Rouphael, AT Widge, LA Jackson… - vinculo.semergen.es
Antecedentes: La vacuna mRNA-1273 frente al SARS-CoV-2 de Moderna ha mostrado
aceptable perfil de seguridad, siendo inmunogénica y generando anticuerpos …
aceptable perfil de seguridad, siendo inmunogénica y generando anticuerpos …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
EJ Anderson, NG Rouphael, AT Widge… - New England Journal …, 2020 - cir.nii.ac.jp
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.
EJ Anderson, NG Rouphael, AT Widge, LA Jackson… - 2020 - cabidigitallibrary.org
Background: Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
EJ Anderson, NG Rouphael, AT Widge… - The New England …, 2020 - europepmc.org
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
EJ Anderson, NG Rouphael… - The New England …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …